🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Several professionals stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and customer regulations, risking penalties, legal action or prison.

Service Reaction and Material Removal

According to the social media company, the platform has taken down problematic content and prohibited related keywords and search suggestions. The company stated it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing reviews and detailed guides for mixing or injecting at residence.

Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.

Item Information and Costs

Inside these groups, messages display black plastic packages with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially significant medical dangers”.